Influence of dietary isoflavone intake on gastrointestinal symptoms in ulcerative colitis individuals in remission

Table 3 Isoflavone intake levels in groups of ulcerative colitis individuals declaring lack of flatulence and declaring presence of flatulence (comparison conducted using U Mann-Whitney test)

	Individuals declaring lack of flatulence (n = 46)		Individuals declaring flatulence (n = 10)		P value
	Mean ± SD	Median (min-max)	Mean ± SD	Median (min-max)
Intake
Daidzein (μg)	147.4 ± 165.6	115.01 (3.3-977.7)	131.4 ± 843	109.8 (19.0-278.0)	0.7727
Genistein (μg)	187.6 ± 225.4	140.01 (2.3-1428.3)	131.1 ± 177.6	78.31 (7.3-586.7)	0.2186
Glycitein (μg)	2.2 ± 9.7	0.01 (0.0-56.0)	0.4 ± 1.3	0.01 (0.0-4.0)	0.7738
Total isoflavones (μg)	337.2 ± 293.4	302.51 (18.0-1574.0)	262.9 ± 232.2	220.81 (37.3-833.0)	0.4162
Intake per 1000 kcal
Daidzein (μg/1000 kcal)	78.9 ± 89.1	53.91 (1.3-392.7)	74.3 ± 56.6	60.8 (12.1-56.6)	0.6455
Genistein (μg/1000 kcal)	97.3 ± 121.5	68.11 (1.4-759.2)	79.4 ± 128.7	32.31 (3.6-426.6)	0.2268
Glycitein (μg/1000 kcal)	1.4 ± 6.1	0.01 (0.0-37.4)	0.3 ± 0.9	0.01 (0.0-2.9)	0.7738
Total isoflavones (μg /1000 kcal)	177.6 ± 162.9	133.51 (8.3-836.7)	154.0 ± 170.0	133.91 (21.7-605.7)	0.5854

¹Nonparametric distribution (verified using the Shapiro-Wilk test; P < 0.05).